Clinical Trial: Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298395) titled 'Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis' on Dec. 10.

Brief Summary: The goal of this clinical trial is to learn about the safety and effectiveness of ENV-294 in adults with moderate to severe atopic dermatitis.

The main questions it will answer are:

* Is there an impact on the severity and area of atopic dermatitis when participants take ENV-294

* What medical problems do participants have when taking ENV-294 Researchers will review the atopic dermatitis present at the beginning of the study against the atopic dermatitis present at the end of the study.

Participants will:

* Take drug ENV-294 or a pl...